Commentary: Indirect comparisons: a novel approach to assessing the effect of anti-HIV drugs.

Comments on the importance of fast and effective assessment programs for anti-HIV drugs. Comparison of the effects of drugs from either the protease inhibitor or the non-nucleoside reverse transcriptase inhibitors; How most randomized trials focus on the factors that influence virological failure; Launch of programs to provide anti-HIV therapy to 3 million people by the World Health Organization before the end of 2005; Reference to research by Y. Yazdanpanah and coworkers.